Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05078658
Other study ID # NU21-01-00085
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date September 22, 2021
Est. completion date October 2024

Study information

Verified date May 2024
Source University Hospital, Motol
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary aim of this pilot study is to test whether low-carbohydrate diet (LCD) instituted in children/adolescents with type 1 diabetes (T1D) can improve their disease control. The primary objective of the trial is the change in continuous glucose monitoring time in target range 3.9-10.0 mmol/l (TIR) in a 5-week period on LCD as opposed to a 5-week period on recommended carbohydrate diet (RCD). Secondary objectives are: Changes in immune parameters during the LCD period; Differences in fecal microbiome during the LCD period; Differences in fecal, serum and urine metabolome during the LCD period;


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 35
Est. completion date October 2024
Est. primary completion date October 2024
Accepts healthy volunteers No
Gender All
Age group 6 Years to 20 Years
Eligibility Inclusion Criteria: - T1D diagnosed according to the ADA (American Diabetes Assocciation) criteria - T1D duration for at least 1 year prior to the intervention - continuous glucose monitor (CGM) worn > 70% time in the month prior to the intervention Exclusion Criteria: - last HbA1c < 40 or > 70 mmol/mol - subject has celiac disease - daily average carbohydrate intake < 130 g/day from 14 days food record prior to the intervention - any concomitant disease possibly affecting glucose control - any chronic medication possibly affecting glucose control

Study Design


Intervention

Other:
Low-carbohydrate diet
The diet will contain age- and gender-specific recommended amount of calories but the amount of carbohydrates would be limited to provide only 15% (+/- 5%) of the recommended energy a day.
Recommended-carbohydrate diet
The subjects will be delivered five pre-made ready meals per day throughout the period (5 weeks). These will contain age- and gender-specific recommended amount of calories with the amount of carbohydrates equal to 45% (+/- 5%) of the recommended energy a day.

Locations

Country Name City State
Czechia University Hospital Motol Prague

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Motol Czech Academy of Sciences

Country where clinical trial is conducted

Czechia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in continuous glucose monitoring time in target range (3.9-10.0 mmol/l) during the LCD period compared to the RCD period Month 1 - Month 24
Secondary Changes in mean insulin dose during the LCD period compared to the RCD period Month 1 - Month 24
Secondary Changes in mean body weight standard deviation score during the LCD period compared to the RCD period Month 1 - Month 24
Secondary Changes in the lipid spectrum during the LCD period compared to the RCD period Month 1 - Month 24
Secondary Changes in muscle strength measured by jumping mechanography during the LCD period compared to the RCD period Month 1 - Month 24
Secondary Changes in lymphocyte subgroup cell counts (flow cytometry) during the LCD period Month 1 - Month 36
Secondary Differences in faecal microbiome between the LCD and RCD periods Month 1 - Month 36
Secondary Differences in faecal metabolome between the LCD and RCD periods Month 1 - Month 36
Secondary Differences in serum metabolome between the LCD and RCD periods Month 1 - Month 36
Secondary Differences in urine metabolome between the LCD and RCD periods Month 1 - Month 36
See also
  Status Clinical Trial Phase
Completed NCT03886974 - Transition to Adult Care in Type 1 Diabetes
Completed NCT05620251 - Response to BNT162b2 Vaccine in Adolescents With Type 1 Diabetes
Completed NCT03623113 - The Dietary Education Trial in Carbohydrate Counting (DIET-CARB Study in Type 1 Diabetes N/A
Not yet recruiting NCT06018324 - CloudCare in the Treatment of Type 1 Diabetes in Pediatrics
Withdrawn NCT03736083 - Introducing CGM at Type 1 Diabetes Diagnosis N/A
Completed NCT03177096 - Impact of the Continuous Measurement of Blood Glucose on Insulin Pump on Child Quality of Life With Type 1 Diabetes N/A
Not yet recruiting NCT06418269 - The Effect of Therapeutic Play on Anxiety and Fear Levels in Children With Diabetes N/A
Completed NCT04172077 - Self Efficacy Levels, Attachment Style and Resiliency of Youth With Type 1 Diabetes
Recruiting NCT04950634 - Sexual Dimorphism in Cardiovascular Autonomic Neuropathy in Patients With Type 1 Diabetes
Completed NCT04450745 - Physical Exercise in Normobaric Hypoxia and Normoxia in Type 1 Diabetic Patients N/A
Completed NCT03165786 - A Cognitive Behavioral Intervention to Reduce Fear of Hypoglycemia in Young Adults With Type 1 Diabetes N/A
Terminated NCT04028960 - IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only Phase Phase 2
Recruiting NCT05324488 - Diabetes Registry Graz for Biomarker Research
Completed NCT02984709 - Check It! 2.0: Positive Psychology Intervention for Adolescents With Type 1 Diabetes N/A
Completed NCT02984514 - Brown Adipose Tissue in Type 1 Diabetes N/A
Recruiting NCT06372392 - Universal Fixed Meal Boluses Usage in Patients With Medtronic Minimed 780G Pumps N/A
Recruiting NCT05973799 - Effect of Fasting on Hypoglycemic Counterregulation in Type 1 Diabetes N/A
Recruiting NCT03311516 - New Insulin Therapy by Multiwave Bolus N/A
Completed NCT03711656 - Prediction and Prevention of Nocturnal Hypoglycemia in Persons With Type 1 Diabetes Using Machine Learning Techniques N/A
Recruiting NCT05737654 - The Effect of Exercise on Metabolic Parameters, Anthropometric Measurement Values and Quality of Life N/A